• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无法切除的肝门周围胆管癌患者的条件生存情况。

Conditional survival in patients with unresectable perihilar cholangiocarcinoma.

作者信息

Gaspersz Marcia P, Buettner Stefan, van Vugt Jeroen L A, Roos Eva, Coelen Robert J S, Vugts Jaynee, Belt Eric J, de Jonge Jeroen, Polak Wojciech G, Willemssen François E J A, van Gulik Thomas M, IJzermans Jan N M, Groot Koerkamp Bas

机构信息

Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

出版信息

HPB (Oxford). 2017 Nov;19(11):966-971. doi: 10.1016/j.hpb.2017.07.004. Epub 2017 Jul 25.

DOI:10.1016/j.hpb.2017.07.004
PMID:28754366
Abstract

BACKGROUND

Conditional survival is the life expectancy from a point in time for a patient who has survived a specific period after presentation. The aim of the study was to estimate conditional survival for patients with unresectable perihilar cholangiocarcinoma.

METHODS

Patients with unresectable perihilar cholangiocarcinoma from two academic hospitals in the Netherlands between 2002 and 2012 were assessed. A multivariable Cox proportional hazards analysis was performed to identify risk factors associated with overall survival. Survival was estimated using the Kaplan-Meier method to evaluate factors associated with overall survival.

RESULTS

In total, 572 patients were included. Overall survival was 42% at one year and 6% at three years. The conditional chance of surviving three years was 15% at 1 year and increased to 38% at 2 years. Independent poor prognostic factors for overall survival were age ≥65 years, tumor size >3 cm on imaging, bilirubin levels (>250 μmol/L), CA19-9 level at presentation (>1000 U/ml), and suspected distant metastases on imaging. The conditional survival of patients with and without these prognostic factors was comparable after patients survived the first two or more years.

CONCLUSION

The conditional chance of surviving for patients with unresectable perihilar cholangiocarcinoma increases with time. Poor prognostic factors become less relevant once patients have survived two years.

摘要

背景

条件生存是指患者在出现症状后存活特定时间段后的预期寿命。本研究的目的是估计不可切除的肝门部胆管癌患者的条件生存情况。

方法

对2002年至2012年期间荷兰两家学术医院的不可切除肝门部胆管癌患者进行评估。进行多变量Cox比例风险分析以确定与总生存相关的危险因素。使用Kaplan-Meier方法估计生存情况以评估与总生存相关的因素。

结果

共纳入572例患者。1年时总生存率为42%,3年时为6%。1年时生存3年的条件概率为15%,2年时增至38%。总生存的独立不良预后因素为年龄≥65岁、影像学检查肿瘤大小>3 cm、胆红素水平(>250 μmol/L)、初诊时CA19-9水平(>1000 U/ml)以及影像学检查怀疑有远处转移。在患者存活两年或更长时间后,有和没有这些预后因素的患者的条件生存情况相当。

结论

不可切除的肝门部胆管癌患者的条件生存概率随时间增加。一旦患者存活两年,不良预后因素的相关性就会降低。

相似文献

1
Conditional survival in patients with unresectable perihilar cholangiocarcinoma.无法切除的肝门周围胆管癌患者的条件生存情况。
HPB (Oxford). 2017 Nov;19(11):966-971. doi: 10.1016/j.hpb.2017.07.004. Epub 2017 Jul 25.
2
Percutaneous Transhepatic Biliary Stent Implantation for Obstructive Jaundice of Perihilar Cholangiocarcinoma: A Prospective Study on Predictors of Stent Patency and Survival in 92 Patients.经皮肝穿刺胆管支架植入术治疗肝门部胆管癌所致梗阻性黄疸:92例患者支架通畅及生存预测因素的前瞻性研究
J Vasc Interv Radiol. 2016 Jul;27(7):1047-1055.e2. doi: 10.1016/j.jvir.2016.02.035. Epub 2016 May 27.
3
Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.不可切除性肝门部胆管癌患者基于炎症的预后评分评估
J Hepatobiliary Pancreat Sci. 2016 Oct;23(10):636-642. doi: 10.1002/jhbp.386. Epub 2016 Aug 30.
4
Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.评估肝门部胆管癌的临床结局。
Hepatobiliary Pancreat Dis Int. 2018 Apr;17(2):155-162. doi: 10.1016/j.hbpd.2018.03.003. Epub 2018 Mar 6.
5
Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?术前和术后CA19-9水平能否预测可切除肝门部胆管癌患者的生存及早期复发情况?
Oncotarget. 2017 Jul 11;8(28):45335-45344. doi: 10.18632/oncotarget.17336.
6
Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.可切除性肝门部胆管癌患者预后列线图的建立与验证
Oncotarget. 2016 Jun 14;7(24):37319-37330. doi: 10.18632/oncotarget.9104.
7
Prognostic Significance of the Histologic Response of Perihilar Cholangiocarcinoma to Preoperative Neoadjuvant Chemoradiation in Liver Explants.肝外植体中肝门部胆管癌对术前新辅助放化疗的组织学反应的预后意义
Am J Surg Pathol. 2016 Apr;40(4):510-8. doi: 10.1097/PAS.0000000000000588.
8
Analysis of treatment methods and prognostic factors in 354 cases of hilar cholangiocarcinoma: A cohort study.354例肝门部胆管癌治疗方法及预后因素分析:一项队列研究。
J Cancer Res Ther. 2020;16(2):230-237. doi: 10.4103/jcrt.JCRT_637_19.
9
Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma.围手术期输血与肝门部胆管癌切除术后的总生存期或复发时间无关。
HPB (Oxford). 2016 Mar;18(3):262-70. doi: 10.1016/j.hpb.2015.08.004. Epub 2016 Jan 6.
10
Intrahepatic, perihilar and distal cholangiocarcinoma: Management and outcomes.肝内、肝门周围及肝外胆管癌:治疗与预后
Ann Hepatol. 2017;16(1):133-139. doi: 10.5604/16652681.1226927.

引用本文的文献

1
Endobiliary radiofrequency ablation in recurrence and unresectable Perihilar cholangiocarcinoma.肝门部胆管癌复发及不可切除病例的胆管内射频消融术
BMC Gastroenterol. 2025 Jul 7;25(1):501. doi: 10.1186/s12876-025-04104-6.
2
Interpretation of mebrofenin and etifenin hepatobiliary scintigraphy before major liver resection.肝大部切除术前美布芬宁和依替菲宁肝胆闪烁显像的解读
Langenbecks Arch Surg. 2024 Apr 9;409(1):114. doi: 10.1007/s00423-024-03302-2.
3
Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible.
肝门部胆管癌右侧肝切除术后较高的术后死亡率和较差的生存率:可能的情况下首选左侧肝切除。
Ann Surg Oncol. 2024 Jul;31(7):4405-4412. doi: 10.1245/s10434-024-15115-0. Epub 2024 Mar 12.
4
How Can Machine Perfusion Change the Paradigm of Liver Transplantation for Patients with Perihilar Cholangiocarcinoma?机器灌注如何改变肝门部胆管癌患者肝移植的模式?
J Clin Med. 2023 Mar 3;12(5):2026. doi: 10.3390/jcm12052026.
5
Conditional Survival After Hepatectomy for Colorectal Liver Metastasis: Results from the Colorectal Liver Operative Metastasis International Collaborative (COLOMIC).结直肠癌肝转移肝切除术后的条件生存:来自结直肠癌肝转移国际协作(COLOMIC)的研究结果。
Ann Surg Oncol. 2023 Jun;30(6):3413-3422. doi: 10.1245/s10434-023-13189-w. Epub 2023 Mar 1.
6
CT-Based Radiomics Analysis for Noninvasive Prediction of Perineural Invasion of Perihilar Cholangiocarcinoma.基于CT的放射组学分析用于肝门部胆管癌神经周围侵犯的无创预测
Front Oncol. 2022 Jun 20;12:900478. doi: 10.3389/fonc.2022.900478. eCollection 2022.
7
Comparison of Intraductal RFA Plus Stent versus Stent-Only Treatment for Unresectable Perihilar Cholangiocarcinoma-A Systematic Review and Meta-Analysis.导管内射频消融联合支架与单纯支架治疗不可切除肝门部胆管癌的比较——一项系统评价和荟萃分析
Cancers (Basel). 2022 Apr 21;14(9):2079. doi: 10.3390/cancers14092079.
8
Actual 10-Year Survival after Resection of Perihilar Cholangiocarcinoma: What Factors Preclude a Chance for Cure?肝门部胆管癌切除术后的实际10年生存率:哪些因素排除了治愈的机会?
Cancers (Basel). 2021 Dec 13;13(24):6260. doi: 10.3390/cancers13246260.
9
A Novel Nomogram Based on Log Odds of Metastatic Lymph Nodes to Predict Overall Survival in Patients With Perihilar Cholangiocarcinoma After Surgery.一种基于转移性淋巴结对数比值的新型列线图,用于预测肝门部胆管癌患者术后的总生存期。
Front Oncol. 2021 Jul 22;11:649699. doi: 10.3389/fonc.2021.649699. eCollection 2021.
10
Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification.泰国东北部胆管癌患者根据解剖学和形态学分类的手术后生存率。
BMC Cancer. 2021 May 3;21(1):497. doi: 10.1186/s12885-021-08247-z.